EGFR-V834L combined with L858R mutation reduced afatinib sensitivity and associated to early recurrence in lung cancer.
Terada N, Koba H, Nanjo S, Kimura H, Nishiyama A, Yoneda T, Takeda T, Shirasaki H, Nishi K, Sone T, Yamada T, Takayama K, Shibata K, Matsuoka H, Kita T, Nagata K, Tambo Y, Ohkura N, Hara J, Kasahara K, Kohsaka S, Mano H, Yano S.
Terada N, et al. Among authors: sone t.
Transl Lung Cancer Res. 2024 Nov 30;13(11):3067-3082. doi: 10.21037/tlcr-24-471. Epub 2024 Nov 28.
Transl Lung Cancer Res. 2024.
PMID: 39670006
Free PMC article.